Ari M. Melnick

Weill Cornell Medicine

NIH Rank #6047
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#6,047
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 3 grants · National rank #6047.

Top grants by award amount

Ari M. Melnick's NIH grant portfolio, ranked by award amount.

  • 5R35CA220499-07R35
    Targeting Epigenetic Circuits in B-Cell Lymphomas
    $965.7K
    award amount
  • 5R01CA270243-02R01
    Therapeutic targeting of SIRT3 for aggressive and refractory lymphomas
    $645.9K
    award amount
  • 1P01CA272295-01A1P01
    Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche
    $258.8K
    award amount

Affiliation

Institutions that have administered grants for Ari M. Melnick.

Affiliated with Weill Cornell Medicine (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6047